cardiology diagnostic News
-
BioSerenity, Inc. appoints new leadership in North America
BioSerenity, a high-growth company specializing in research and remote diagnostic solutions for neurology, sleep medicine, and cardiology, announces Jeff Wren’s appointment as Chief Executive Officer of North America. Jeff Wren assumes the leadership role in the states as Pierre Frouin, CEO of BioSerenity, moves back to Europe. Since its expansion to the United States in 2019, ...
By BioSerenity
-
Premier Inc. Awards BioSerenity Contract
BioSerenity, Inc., a leading global provider of diagnostic solutions in the areas of Sleep Medicine, Neurology, and Cardiology, announced today it has been awarded a group purchasing agreement for PP-SV-268 by Premier as part of its Preferred Partner agreement. The prevalence of sleep disorders, epilepsy and cardiovascular disease pose a significant challenge to the US healthcare system. ...
By BioSerenity
-
FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR
Dr. Roberto Diletti from The Erasmus Center in Rotterdam, Netherlands, presented the results of the two-year follow-up analysis of the FFR-SEARCH observational registry during the EuroPCR conference in Paris. The analysis evaluated the outcomes of patients and prognostic value of post-percutaneous coronary intervention (post-PCI) FFR assessment, indicating patients with a lower FFR post-PCI ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you